Physician profile
Ushma Sheth
NPI 1730576364
$373.84
in general payments reported to CMS, 2019-2025
14 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $18.41 · 2020: $22.71 · 2021: $17.83 · 2023: $60.49 · 2024: $153 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $314.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $78.97 | 2024-2025 | Krystexxa |
| Becton, Dickinson and Company | $51.41 | 2024 | Venclose Maven Catheter |
| Paratek Pharmaceuticals, INC. | $37.65 | 2024-2025 | Nuzyra |
| Polymedics Innovations INC. | $27.00 | 2023 | |
| Smith+Nephew, INC. | $22.71 | 2020 | |
| Ani Pharmaceuticals, INC. | $22.09 | 2025 | Sovuna |
| Surgenex LLC | $20.47 | 2025 | Surgraft, Surmatrix, Pellograft |
| Nevro Corp. | $19.80 | 2023 | Senza |
| Integra Lifesciences Corporation | $18.41 | 2019 | |
| Bard Peripheral Vascular, INC. | $18.09 | 2024 | Venclose Maven Catheter |
| Zimmer Biomet Holdings, INC. | $17.83 | 2021 | |
| Treace Medical Concepts, INC. | $14.37 | 2024 | |
| Organogenesis INC. | $13.69 | 2023 | Puraply |
| Orthofix Medical, INC. | $11.35 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ushma Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.